Sunday, September 07, 2003 1:40:21 AM
+++++++++++++++
A particular focus, according to the NIH, will be the construction of haplotypes for pharmacogenetic prediction.
++++++++++++++
It seems that they are accepting applications for studies in the neighborhood that DNAP is the sharpest knife. Now when NIH can finally get thier act together, DNAP will be selling product based on completed studies. Not a prediction, but simply a hopeful thought based on a limited understanding of some very complex issues. (WAG).
If nothing else, the pharmacoGENETIC word is very important, at least to my eyes.
Stakddek
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM